Matthew A. Roberts

Over the course of his 25-year career, Dr. Roberts has held senior executive roles at leading companies including Nestlé, Abbott, Pharmavite, and Niagen Bioscience. His experience includes establishing a corporate venture fund at Nestlé focused on health innovation, co-leading at Abbott a public-private partnership with the University of Illinois that helped create the Center for Nutrition, Learning, and Memory, and expanding external research efforts at Niagen Bioscience, formerly ChromaDex, in support of peer-reviewed publications, regulatory progress, and new business areas focused on mitochondrial health. He also advises emerging companies and nonprofit organizations and has contributed to peer-reviewed work relating to scientific and technological innovation in human health. Dr. Roberts holds a Ph.D. in Toxicology from Cornell University, an MBA from Washington University in St. Louis, and a B.Sc. in Molecular Biology from Purdue University.

In his role as Public Health, Public Safety, and Defense Advisor, Dr. Roberts will provide strategic business and technical guidance to Redwood on the application of its artificial intelligence platform to complex challenges at the intersection of public health and public safety. His work focuses on translating advanced chemistry and AI capabilities into operational systems that support frontline professionals across law enforcement, healthcare, and regulatory decision-making. Dr. Roberts currently serves as Managing Director of Aidos Innovations, a nonprofit translational science institute developed in collaboration with the University of British Columbia and the IMAPP research program at Vancouver General Hospital. Aidos is focused on advancing technologies that bridge clinical insight, scientific innovation, and system-level implementation in response to the evolving opioid crisis and related public health challenges. Through this lens, Dr. Roberts brings experience in developing and operationalizing platforms such as Track & Trace, an integrated chemical intelligence system combining advanced analytical chemistry, data infrastructure, and cross-sector collaboration to generate actionable insights on illicit drug supply and its impact on communities.